MRI Predicts Prostate Cancer Upgrading at First Active Surveillance ...
WEB1 day ago · October 3, 2024. Baseline MRI PI-RADS score suggests prognosis and may improve upfront risk stratification and eligibility for prostate cancer active surveillance. Higher baseline MRI PI-RADS ...
Urology & Nephrology News, Treatment Studies | Renal, Urology …
WEBBy John Schieszer, MA. A proposed 2025 Physician Fee Schedule conversion factor of $32.36 represents a 2.8% decrease from 2024.
Cannabis Cream May Treat Pruritus in Patients on Hemodialysis
WEB1 day ago · Cannabis cream relieved itching symptoms over the short-term in a small trial of patients on hemodialysis experiencing uremic pruritus. In the double-blind trial (Clinicaltrials.gov Identifier ...
Risk of Late Biochemical Recurrence “Strikingly Low” in Certain ...
WEB3 days ago · References: Hoeh B, Preisser F, Zattoni F, et al. Risk of biochemical recurrence and metastasis in prostate cancer patients treated with radical prostatectomy after a 10-year disease-free interval ...
Regular SARS-CoV-2 Testing in Hemodialysis Facilities …
WEB3 days ago · References: Montez-Rath M, Varkila M, Yu X, et al. Acceptance of SARS-CoV-2 surveillance testing among patients receiving dialysis: a cluster randomized trial. JAMA Netw Open. 2024 Sep 3;7(9). doi ...
News Archive - Renal and Urology News
WEB5 days ago · Probiotic, Prebiotic, and Synbiotic Supplements Have Favorable Effect in MASLD. Researchers investigated the effect of microbiota therapy on the liver among patients with metabolic dysfunction ...
Semaglutide Improves Kidney Outcomes in High-Risk Patients
WEBMay 28, 2024 · References: Perkovic V, Tuttle KR, Rossing P, et al. Effects of semaglutide on chronic kidney disease in patients with type diabetes. N Eng J Med.Published online May 24, 2024. doi:10.1056 ...
Sibeprenlimab Shows Promise for IgA Nephropathy
WEBJan 25, 2024 · Sibeprenlimab significantly reduces proteinuria in patients with high-risk IgA nephropathy (IgAN), according to trial results published in The New England Journal of Medicine.. In the ...
Adjuvant Nivolumab Shows Durable Benefit in High-Risk MIUC
WEBJun 2, 2022 · The data show that nivolumab continued to maintain a clinically meaningful improvement in disease-free survival (DFS). CheckMate 274 included 709 patients with high-risk MIUC. Investigators ...
Kidney Function Declines More Slowly With SGLT2 Inhibitor
WEBNov 7, 2022 · Mean eGFR declined more slowly per year with empagliflozin vs DPP4i treatment: -1.33 vs -2.26 mL/min/1.73 m 2 per year, Dr Mosenzon reported on behalf of his team. The eGFR slope became gentler ...